An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication

Basit Öğe Kaydı
dc.authoridkartalcı, şükrü/0000-0003-2560-0355
dc.authoriduslu, mustafa özay/0000-0002-9707-1379
dc.authorwosidDundar, Serkan/V-8159-2018
dc.authorwosidkartalcı, şükrü/ABI-1106-2020
dc.authorwosiduslu, mustafa özay/S-7657-2019
dc.contributor.authorEltas, A.
dc.contributor.authorKartalci, S.
dc.contributor.authorEltas, S. D.
dc.contributor.authorDundar, S.
dc.contributor.authorUslu, M. O.
dc.date.accessioned2024-08-04T20:37:32Z
dc.date.available2024-08-04T20:37:32Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground and objective: Severe periodontal disease is prevalent among patients with schizophrenia and is caused by the side effect of their medication, poor dental hygiene and smoking. The objective of this study was to evaluate whether the rate of periodontal disease could be modulated by changing the salivary flow rate (SFR) because of the use of antipsychotic medications in patients with schizophrenia. Methods: Group A (n=33) included patients who used medications that may cause xerostomia, or dry mouth and Group B (n=20) included patients who used medications that may cause sialorrhea, an excessive secretion of saliva. The participants' periodontal status was assessed using the plaque index (PI), assessing bleeding on probing (BoP), probing pocket depth (PPD) and clinical attachment levels (CAL). Results: The mean of PI and BoP was significantly higher in Group A than in Group B (P<0.001), but the PPD, CAL and decayed, missing and filled teeth (DMFT) scores were not significantly different in the two groups according to the statistical results (0.05). Conclusions: The researcher concluded that there is a high risk of periodontal disease among patients with schizophrenia, and there is an even higher risk of periodontal disease induced by medication that increased SFR. Preventive dental protocol should be increased during the dental health care of this disadvantaged patient group.en_US
dc.identifier.doi10.1111/j.1601-5037.2012.00558.x
dc.identifier.endpage83en_US
dc.identifier.issn1601-5029
dc.identifier.issue2en_US
dc.identifier.pmid22583707en_US
dc.identifier.scopus2-s2.0-84876330918en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage78en_US
dc.identifier.urihttps://doi.org/10.1111/j.1601-5037.2012.00558.x
dc.identifier.urihttps://hdl.handle.net/11616/96011
dc.identifier.volume11en_US
dc.identifier.wosWOS:000317594700002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofInternational Journal of Dental Hygieneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectperiodontitisen_US
dc.subjectsalivary flowen_US
dc.subjectschizophreniaen_US
dc.titleAn assessment of periodontal health in patients with schizophrenia and taking antipsychotic medicationen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu